Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Various cytoskeletal proteins have been implicated in the cellular pathology of Alzheimer's disease. A monoclonal antibody (SMI32) that recognizes nonphosphorylated epitopes on the medium (168 kDa) and heavy (200 kDa) subunits of neurofilament proteins has been used to label and analyze a specific subpopulation of pyramidal neurons in the prefrontal and inferior temporal cortices of normal and Alzheimer's disease brains. In Alzheimer's disease, the distribution of neuropathological markers predominates in layers III and V in these association areas. In these neocortical regions, SMI32 primarily labels the perikarya and dendrites of large pyramidal neurons, predominantly located within layers III and V. In Alzheimer's disease, a dramatic loss of SMI32-immunoreactive (ir) cells was observed, affecting particularly the largest cells (i.e., cells with a cross-sectional perikaryal area larger than 350 microns 2). The staining intensity of the largest SMI32-ir neurons was significantly reduced in Alzheimer's disease cases, suggesting that an inappropriate phosphorylation of these cytoskeletal proteins may take place in the course of the pathological process. In addition, the SMI32-ir neuron loss and total neuron loss were highly correlated with neurofibrillary tangle counts, whereas such a correlation was not observed with neuritic plaque counts. These quantitative data suggest that SMI32-ir neurons represent a small subset of pyramidal cells that share certain anatomical and molecular characteristics and are highly vulnerable in Alzheimer's disease. Other studies have suggested that SMI32-ir neurons are likely to furnish long corticocortical projections. Thus, their loss would substantially diminish the effectiveness of the distributed processing capacity of the neocortex, resulting in a neocortical isolation syndrome as reflected by the clinical symptomatology observed in these patients. Such correlations between the expression of a selective cellular pathology and specific elements of cortical circuitry will increase our understanding of the molecular and cellular characteristics underlying a given neuronal subclass vulnerability in Alzheimer's disease or other neurodegenerative disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neuron loss is a basic and fundamental feature in the pathogenesis of AD [18,19], starting already at preclinical stages when the neuropathological hallmarks are not yet present [20].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [19]
In the citing paper
“For example, there was a selective loss of excitatory neurons in the supragranular layers (L2/3 IT)9,54.”
From Integrated multimodal cell atlas of Alzheimer’s disease (2024) · cites this paper as [54]
In the citing paper
“In humans, neurons in the prefrontal cortex with specialization such as these exhibit enhanced susceptibility to neurodegeneration in the course of disorders like Alzheimer’s disease (31–34).”
From Evolution of increased glia–neuron ratios in the human frontal cortex (2006) · cites this paper as [33]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Circuitry of Primate Prefrontal Cortex and Regulation of Behavior by Representational Memory
Goldman‐Rakic, P. S. (1987) · Comprehensive Physiology · doi:10.1002/cphy.cp010509 · Cited by 1,960
AN ANATOMICAL STUDY OF CONVERGING SENSORY PATHWAYS WITHIN THE CEREBRAL CORTEX OF THE MONKEY
JONES, E. G., & POWELL, T. P. S. (1970) · Brain · doi:10.1093/brain/93.4.793 · Cited by 1,711
Topography of Cognition: Parallel Distributed Networks in Primate Association Cortex
Goldman-Rakic, P. S. (1988) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.11.030188.001033 · Cited by 1,660
Katzman, R., Terry, R., DeTeresa, R., Brown, T., Davies, P., Fuld, P., Renbing, X., & Peck, A. (1988) · Annals of Neurology · doi:10.1002/ana.410230206 · Cited by 1,225
Sternberger, L. A., & Sternberger, N. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.6126 · Cited by 1,158
The functional logic of cortical connections
Zeki, S., & Shipp, S. (1988) · Nature · doi:10.1038/335311a0 · Cited by 1,067
Principles of behavioral neurology
Mesulam, M. M. (1985) · Davis eBooks · Cited by 991
Research works printed but not linked: 7
- Campbell M. J., 1989, A subset of primate corticocortical neurons are neurofilament protein (NFP) immunoreactive (ir): a combined retrograde immunohistochemical study, Proc. Soc. Neurosci., 15, 72
- Gambetti P., 1987, Neurochemistry of Aging, 309
- Goldman‐Rakic P. S., 1987, Handbook of Physiology, 373
- Hof P. R., 1988, Quantitative analysis of non‐phosphorylated neurofilament protein (NPNFP)‐immunoreactive neurons in normal and Alzheimer's disease brain, Proc. Soc. Neurosci., 14, 1086
- Morrison J. H., 1986, The Biological Substrates of Alzheimer's Disease, UCLA Forum in Medical Sciences, 115
- Morrison J. H., 1987, Molecular Neuropathology of Aging. Banbury Report, 109
- Rapoport S. I., 1987, Molecular Neuropathology of Aging, Banbury Report, 37
Cited by
Items 201–300 of 366
Expression of GFAP and Tau Following Blast Exposure in the Cerebral Cortex of Ferrets
Schwerin, S. C., Chatterjee, M., Hutchinson, E. B., Djankpa, F. T., Armstrong, R. C., McCabe, J. T., Perl, D. P., & Juliano, S. L. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa157 · Cited by 35
“Several clinical studies report that TBI-induced tau histopathology occurs in the upper layers of the cerebral cortex, as we see here in ferrets, compared with pathology manifest in Alzheimer disease (depending on the cytoarchitectonic area), mainly in the pyramidal cells of layers 3 and 5 (19, 56).”
Giannakopoulos, P., Bouras, C., & Hof, P. R. (1994) · Acta Neuropathologica · doi:10.1007/bf00389496 · Cited by 37
“This observation supports the hypothesis that SP formation is related to the loss of corticocortical projection neurons [24, 26-28 , 37, 39, 41].”
BackgroundResultSelf-citationDecreased neurofilament gene expression is an index of selective axonal hypotrophy in ageing
Kuchel, G. A., Poon, T., Irshad, K., Richard, C., Julien, J., & Cowen, T. (1996) · Neuroreport · doi:10.1097/00001756-199605310-00004 · Cited by 34
Motor Cortex Involvement in Presenile Dementia: Report of a Case
Golaz, J., Bouras, C., & Hof, P. R. (1992) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/002383099200500205 · Cited by 36
Self-citationBerg, J., Sorensen, S. A., Ting, J. T., Miller, J. A., Chartrand, T., Buchin, A., Bakken, T. E., Budzillo, A., Dee, N., Ding, S.-L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.31.018820 · Cited by 33
Vickers, J. C. (1997) · Australian and New Zealand Journal of Ophthalmology · doi:10.1111/j.1442-9071.1997.tb01290.x · Cited by 37
Hof, P. R., Giannakopoulos, P., Vickers, J. C., Bouras, C., & Morrison, J. H. (1995) · Reviews in the Neurosciences · doi:10.1515/revneuro.1995.6.2.97 · Cited by 32
Self-citationWoodhouse, A., Dickson, T. C., West, A. K., McLean, C. A., & Vickers, J. C. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.010 · Cited by 31
Astrocyte changes in aging cerebral cortex and hippocampus: A quantitative immunohistochemical study
Amenta, F., Bronzetti, E., Sabbatini, M., & Vega, J. A. (1998) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(19981001)43:1<29::aid-jemt5>3.0.co;2-h · Cited by 104
Self-citationNeurochemical organization of the primate visual cortex
Morrison, J. H., Hof, P. R., & Huntley, G. W. (1998) · Handbook of chemical neuroanatomy · doi:10.1016/s0924-8196(98)80004-3 · Cited by 36
Self-citationExpression of calcium‐binding proteins and nNOS in the human vestibular and precerebellar brainstem
Baizer, J. S., & Broussard, D. M. (2009) · The Journal of Comparative Neurology · doi:10.1002/cne.22250 · Cited by 32
“The vulnerable cells in the cerebral cortex in Alzheimer’s disease express a nonphosphorylated neurofilament protein and resistant cells express calciumbinding proteins (Hof et al., 1990, 1993; Hof and Morrison, 1990).”
BackgroundPerceptual organization in Alzheimer's disease.
Kurylo, D. D., Corkin, S., & Growdon, J. H. (1994) · Psychology and Aging · doi:10.1037/0882-7974.9.4.562 · Cited by 29
Chapter VIII Primate cingulate cortex chemoarchitecture and its disruption in Alzheimer's disease
Vogt, B. A., Vogt, L. J., Nimchinsky, E. A., & Hof, P. R. (1997) · Handbook of chemical neuroanatomy · doi:10.1016/s0924-8196(97)80010-3 · Cited by 50
Self-citationNeuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets
Herman, F. J., Simkovic, S. J., & Pasinetti, G. M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14569 · Cited by 29
Ayala‐Grosso, C. A., Tam, J. P., Roy, S., Xanthoudakis, S., Costa, D. D., Nicholson, D. W., & Robertson, G. S. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.04.041 · Cited by 32
Functionally relevant measures of spatial complexity in neuronal dendritic arbors
Rothnie, P., Kabaso, D., Hof, P. R., Henry, B. I., & Wearne, S. L. (2005) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2005.06.001 · Cited by 26
“Hof et al.,1995 ),exhibit a different neurochemical phenotype from those providing local projections (Hof et al.,1995 ),and represent a particularly vulnerable class of neurons in Alzheimer’s disease (Morrison et al., 1987; Hof et al.,1990; Hof and Morrison,2004 ).”
BackgroundSelf-citationCalcium-Binding Proteins Define Subpopulations of Interneurons in Cingulate Cortex
Hof, P. R., Lüth, H., ROGERS, J. H., & Celio, M. R. (1993) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4899-6704-6_6 · Cited by 31
Self-citationLiu, Y., Dyck, R. H., & Cynader, M. S. (1994) · Developmental Brain Research · doi:10.1016/0165-3806(94)90301-8 · Cited by 28
Neuroanatomical connections and specific regional vulnerability in Alzheimer's disease
Rebeck, G. W., & Hyman, B. T. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90019-8 · Cited by 31
Willumsen, N., Poole, T., Nicholas, J. M., Fox, N. C., Ryan, N. S., & Lashley, T. (2021) · Brain Pathology · doi:10.1111/bpa.13009 · Cited by 29
Neurochemical organization of the nucleus paramedianus dorsalis in the human
Baizer, J. S., Baker, J. F., Haas, K., & Lima, R. C. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.017 · Cited by 26
Woulfe, J., Hammond, R. R., Richardson, B. S., Sooriabalan, D., Parks, W. R., Rippstein, P. U., & Muñoz, D. G. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00444.x · Cited by 27
“In this context, it is interesting that, in normal cortex, neurofilament-positive neurons show a laminar pattern of distribution identical to that described for INRs (12).”
BackgroundPerceptual Organization Based Upon Spatial Relationships in Alzheimer’s Disease
Kurylo, D. D., Allan, W. C., Collins, T. E., & Baron, J. (2002) · Behavioural Neurology · doi:10.1155/2003/856309 · Cited by 28
Molecular biology of the human phenol sulfotransferase gene family
Dooley, T. P. (1998) · Journal of Experimental Zoology · doi:10.1002/(sici)1097-010x(199809/10)282:1/2<223::aid-jez23>3.0.co;2-t · Cited by 15
Self-citationAdam, S., Bonsang, É., Germain, S., Bay, C., & Perelman, S. (2006) · ORBi (University of Liège) · Cited by 30
Baizer, J. S., Sherwood, C. C., Hof, P. R., Witelson, S. F., & Sultan, F. R. (2011) · The Anatomical Record · doi:10.1002/ar.21400 · Cited by 24
“This observation is consistent with the finding of NPNFP expression in the IOpr and the link between NPNFP expression and the loss of neurons in the cerebral cortex (Hof et al., 1990; Bussiere et al., 2003).”
ResultSelf-citationCerebral and blood correlates of reduced functional connectivity in mild cognitive impairment
González‐Escamilla, G., Atienza, M., García-Solís, D., & Cantero, J. L. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0930-6 · Cited by 29
“V, largely connected through cortico-cortical association fibers (Terry et al. 1981; Rogers and Morrison 1985; Hof et al. 1990).”
BackgroundJacquemont, T., Fallani, F. D. V., Bertrand, A., Epelbaum, S., Routier, A., Dubois, B., Hampel, H. J., Durrleman, S., & Colliot, O. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.03.023 · Cited by 28
“…previous neuroanatomical and neuropathological studies showed that, among the whole brain connections, corticocortical connections and hippocampal circuits are specifically vulnerable to neurodegeneration early in the course of AD (Hof et al., 1990; Hof and Morrison, 1991; Morrison and Hof, 2002).”
BackgroundBlazquez-Llorca, L. (2010) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2010.00020 · Cited by 7
“…of synaptic circuits in which PHF-tau-ir neurons participate is probably very specific (see also Lewis et al., 1987; Hof and Morrison, 1990; Hof et al., 1990, 1995; Arnold et al., 1991; Gomez-Isla et al., 1996; reviewed in Morrison and Hof, 2007). perIcellular InnervatIon of phf-tau-Ir…”
Neurofilament and neural cell adhesion molecule immunocytochemistry of Huntington's disease striatum
Nihei, K., & Kowall, N. W. (1992) · Annals of Neurology · doi:10.1002/ana.410310111 · Cited by 28
Neurodegeneration in the limbic and paralimbic system in progressive supranuclear palsy
Higuchi, Y., Iwaki, T., & Tateishi, J. (1995) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1995.tb01056.x · Cited by 24
Vickers, J. C., Huntley, G. W., Hof, P. R., Bederson, J. B., DeFelipe, J., & Morrison, J. H. (1995) · Brain Research · doi:10.1016/0006-8993(94)01372-o · Cited by 27
“It remains to be determined whether similar changes in non-NMDA receptors may contribute towards the vulnerability of subpopulations of pyramidal neurons as seen in several neurodegenerative diseases [5,13,14,21,22].”
BackgroundSelf-citationNeurodegeneration in juvenile Iberian pigs with diet-induced nonalcoholic fatty liver disease
Zeltser, N., Meyer, I., Hernandez, G. V., Trahan, M. J., Fanter, R. K., Abo-Ismail, M. K., Glanz, H., Strand, C. R., Burrin, D. G., Frano, M. R. L., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00120.2020 · Cited by 26
Immunoreactivity for calretinin and calbindin in the vestibular nuclear complex of the monkey
Baizer, J. S., & Baker, J. F. (2005) · Experimental Brain Research · doi:10.1007/s00221-005-0318-1 · Cited by 24
“Holstein (2000) in a different macaque species also noted calbindin-immunoreactive cells in the VNC.”
BackgroundMiguel-Hidalgo, J., Dubey, P., Shao, Q.-M., Stockmeier, C., & Rajkowska, G. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.015 · Cited by 24
“For example, in Alzheimer’s disease (AD), the packing density of this neuronal subpopulation is dramatically reduced (Hof et al., 1990) and this loss is likely to contribute to the severe cognitive deficits displayed by AD patients.”
BackgroundMethodInfluentialSchizophrenia and Disordered Neural Circuitry
Lewis, D. A. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.3.529 · Cited by 23
“…distribution of neurons containing neurofibrillary tangles in AD closely matches that of neurons in nonhuman primates that have a common profile of axonal projection and biochemical features (Pearson et al. 1985; Lewis et al. 1987; Morrison et al. 1987; Hof et al. 1990; Hof and Morrison 1995).”
BackgroundGai, W., Vickers, J. C., Blumbergs, P. C., & Blessing, W. W. (1994) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.9.1039 · Cited by 23
“…of cortical neurons has been shown to correlate with their propensity to form neurofibrillary tangles present in Alzheimer's disease,'2 13 and neuro-filament immunohistochemistry has been used to identify the early pathological changes in neurons undergoing neurofibrillary…”
Rasia‐Filho, A. A., Guerra, K. T. K., Vásquez, C. E., Dall’Oglio, A., Reberger, R., Jung, C. R., & Calcagnotto, M. E. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.616607 · Cited by 27
“Subpopulations of pyramidal neurons with specific anatomical and molecular profiles may show a differential vulnerability in AD (Morrison et al., 1987; Hof and Morrison, 1990; Hof et al., 1990).”
BackgroundMitew, S., Kirkcaldie, M., Dickson, T. C., & Vickers, J. C. (2013) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2013.00030 · Cited by 24
Kuchela, G. A., Crutcher, K. A., Naheed, U., Thrasivoulou, C., & Cowen, T. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00064-0 · Cited by 22
“For example, although some neurons are prominently involved in early Alzheimer’s disease (AD), many other neuronal populations are spared even in late stages of this disorder [24,35].”
BackgroundGottron, F. J., Turetskya, D., & Choi, D. W. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11698-v · Cited by 22
Driessens, S. L. W., Galakhova, A. A., Heyer, D. B., Pieterse, I. J., Wilbers, R., Mertens, E. J., Waleboer, F., Heistek, T. S., Coenen, L., Meijer, J. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39946-9 · Cited by 25
Sedmak, D., Hrvoj-Mihić, B., Džaja, D., Habek, N., Uylings, H. B. M., & Petanjek, Z. (2018) · Croatian Medical Journal · doi:10.3325/cmj.2018.59.189 · Cited by 23
Markakis, E. A., & Gage, F. H. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990419)406:4<449::aid-cne3>3.0.co;2-i · Cited by 575
Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 30
Baizer, J. S., Wong, K. M., Paolone, N. A., Weinstock, N. I., Salvi, R., Manohar, S., Witelson, S. F., Baker, J. F., Sherwood, C. C., & Hof, P. R. (2014) · The Anatomical Record · doi:10.1002/ar.23000 · Cited by 22
“…to be a marker for glutamatergic cells with long projections, e.g. pyramidal cells of the cerebral cortex of many species (Hof and Morrison, 1990; Hof et al., 1990, 1995, 1997; King et al., 2001; Boire et al., 2005; Van der Gucht et al., 2006; Van der Gucht et al., 2007; Paulussen et al., 2011)…”
BackgroundSelf-citationHof, P. R., & Morrison, J. H. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb03748.x · Cited by 24
Self-citationDecreased neurofilament gene expression is an index of selective axonal hypotrophy in ageing
Kuchel, G. A., Poon, T., Irshad, K., Richard, C., Julien, J., & Cowen, T. (1997) · Neuroreport · doi:10.1097/00001756-199702100-00044 · Cited by 20
(2009) · PubMed · doi:10.14670/hh-24.667 · Cited by 19
“These proteins have been found to be associated with Alzheimer's and other neurodegenerative diseases (Morrison et al., 1987; Hof et al., 1990; Law and Harrison, 2003).”
BackgroundMolecular Mechanisms of Synaptic Disconnection in Alzheimer’s Disease
Masliah, E., Mallory, M. E., Alford, M. F., DeTeresa, R. M., Iwai, A., & Saitoh, T. (1997) · Springer eBooks · doi:10.1007/978-3-642-60680-9_9 · Cited by 22
Molecular signatures of resilience to Alzheimer’s disease in neocortical layer 4 neurons
Dharshini, S. A. P., Sanz‐Ros, J., Pan, J., Tang, W., Vallejo, K., Liu, Y. C., Otero‐García, M., & Cobos, I. (2026) · Nature Communications · doi:10.1038/s41467-026-68920-4 · Cited by 29
“In contrast, we identi fi ed the vulnerability of Ex3 neurons, a distinct subtype of large pyramidal cells in deep layer 3 expressing SV2C and heavy neuro fi laments, which shows robust NFT accumulation and has been previously described to degenerate in AD in immunohistochemical studies 58 .”
Vickers, J. C., Kirkcaldie, M., Phipps, A. J., & King, A. E. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.07.012 · Cited by 19
Miguel, J. C., Perez, S. E., Malek‐Ahmadi, M. H., & Mufson, E. J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.645334 · Cited by 18
“Reductions in SMI-32 staining in cortical neurons are associated with an increase in phosphorylation of the neurofilaments that contribute to NFT formation in AD (Cork et al., 1986; Hof et al., 1990; Morrison and Hof, 2002; Veeranna et al., 2011; Vickers et al., 2016).”
BackgroundResultSynaptic alterations and neuronal firing in human epileptic neocortical excitatory networks
Bod, R.-B., Tóth, K., Essam, N., Tóth, E. Z., Erőss, L., Entz, L., Bagó, A. G., Fabó, D., Ulbert, I., & Wittner, L. (2023) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2023.1233569 · Cited by 21
Connections and Cognitive Impairment in Alzheimer’s Disease
Gómez‐Isla, T., & Hyman, B. T. (1997) · Springer eBooks · doi:10.1007/978-3-642-60680-9_11 · Cited by 20
“As the disease progresses and the cognitive deficits become much broader, NFT can also be found in increasing numbers in feedforward and feedback projection neurons in layers II, III and V of high order association cortices (Lewis et al. 1987; Hof et al. 1990; Arnold et al. 1991).”
BackgroundDyer, M. S., Phipps, A. J., Mitew, S., Taberlay, P. C., & Woodhouse, A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00068 · Cited by 16
Neuronal densities and vascular pathology in the hippocampal formation in CADASIL
Yamamoto, Y., Hase, Y., Ihara, M., Khundakar, A. A., Roeber, S., Duering, M., & Kalaria, R. N. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.09.016 · Cited by 18
“In future investigations, it is imperative to evaluate neuronal densities in other areas of the temporal lobe similar to the frontal lobes (Bussière et al., 2003; Foster et al., 2014; Hof et al., 1990).”
BackgroundBurzynska, A. Z., Wong, C. N., Chaddock‐Heyman, L., Olson, E. A., Gothe, N. P., Knecht, A. M., Voss, M. W., McAuley, E., & Kramer, A. F. (2015) · Neurocase · doi:10.1080/13554794.2015.1074709 · Cited by 20
Somal Size of Immunolabeled Pyramidal Cells in the Prefrontal Cortex of Subjects with Schizophrenia
Maldonado‐Avilés, J. G., Wu, Q., Sampson, A. R., & Lewis, D. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.028 · Cited by 18
Neurochemically defined cell columns in the nucleus prepositus hypoglossi of the cat and monkey
Baizer, J. S., & Baker, J. F. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.113 · Cited by 17
Fanni, D., Gerosa, C., Rais, M., Ravarino, A., Eyken, P. V., Fanos, V., & Faa, G. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.10.063 · Cited by 18
Lu, K., Li, C., Liu, J., Wang, J., Li, Y., He, B., Li, J., Zhang, X., Wei, M., Tian, Y., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2303878120 · Cited by 15
“Three well - established pathological hallmarks of AD are amyloid - β (A β ) plaques, neurofibrillary tangles (NFT), and neuronal loss (10–14).”
BackgroundZeng, X., Puonti, O., Sayeed, A., Herisse, R., Mora, J., Evancic, K., Varadarajan, D., Balbastre, Y., Costantini, I., Scardigli, M., et al. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae362 · Cited by 19
Self-citationZhang, X., Xu, L., Yang, S., Hu, L., Dong, F.-Y., Sun, B., & Shen, H. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210585 · Cited by 17
“Studies of AD patients show that cognitive dysfunction can be associated with abnormal neuronal activity in frontal forebrain regions including the medial prefrontal cortex (mPFC) [1, 2], in which pyramidal neurons are prone to neurodegeneration [3, 4].”
Gatome, C. W., Slomianka, L., Mwangi, D. K., Lipp, H., & Amrein, I. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0239-z · Cited by 15
“This protein also occurs in a subset of cortical neurons selectively lost in Alzheimer’s disease (Hof et al. 1990; Morrison et al. 1987).”
BackgroundHamadelseed, O., Elkhidir, I., & Skutella, T. (2022) · Neurology and Therapy · doi:10.1007/s40120-022-00361-9 · Cited by 17
Changes in cortical circuits during aging
Morrison, J. H., & Hof, P. R. (2003) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(03)00006-9 · Cited by 16
Self-citationNormal Aging in the Cerebral Cortex of Primates
Peters, A. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_3 · Cited by 14
Ha, D. H., Robertson, R. T., & Weiss, J. H. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-11-04201.1998 · Cited by 16
“neurons in culture labeled with the monoclonal antibody SMI-32 that labels subsets of cortical pyramidal neurons in vivo (Morrison et al., 1987; Hof and Morrison, 1990; Hof et al., 1990 ) (see also Fig. 4).”
BackgroundInfluentialSOME “DEPRESSIVE” SYMPTOMS MAY NOT IMPLY DEPRESSION
Royall, D. R. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb01523.x · Cited by 13
Riluzole and Its Prodrugs for the Treatment of Alzheimer’s Disease
Al‐Horani, R. A. (2023) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2023-0001 · Cited by 13
Therapeutics for cognitive aging
Shineman, D. W., Salthouse, T. A., Launer, L. J., Hof, P. R., Bartzokis, G., Kleiman, R. J., Luine, V. N., Buccafusco, J. J., Small, G. W., Aisen, P. S. S., et al. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05532.x · Cited by 14
Self-citationInfluence of aging and neurodegeneration on dendritic spine morphology
Bloss, E. B., Morrison, J. H., Hof, P. R., & Dickstein, D. L. (2011) · Translational Neuroscience · doi:10.2478/s13380-011-0008-3 · Cited by 12
“While AD leads to a loss of principal neurons across multiple cortical areas, local interneuron populations remain unaffected [103-106], suggesting neuronal vulnerability to AD is selective and restricted to pyramidal neuron subtypes.”
BackgroundSelf-citationGlezer, I. I., Hof, P. R., Léránth, C., & Morgane, P. J. (1992) · Springer eBooks · doi:10.1007/978-1-4615-3406-8_1 · Cited by 13
Self-citationShen, Y., Shao, M., Hao, Z.-Z., Huang, M., Xu, N., & Liu, S. (2024) · Neuroscience Bulletin · doi:10.1007/s12264-023-01160-4 · Cited by 11
“…cell types [15]) expressing neurofilament protein SMI-32 (encoded by the NEFH gene), which labels long-range projection neurons in primates that are selectively depleted in AD [157, 158], providing a promising entry to study the pathological mechanism and explore potential therapeutic options.”
BackgroundThe Claustrum in the Squirrel Monkey
Baizer, J. S., Webster, C. J., & Baker, J. F. (2019) · The Anatomical Record · doi:10.1002/ar.24253 · Cited by 10
“This protein is expressed in subsets of cortical pyramidal cells (Campbell and Morrison, 1989; Hof et al., 1990; Hof et al., 1994; Hof et al., 1996) but not by CLA projection neurons.”
BackgroundValla, J., Schneider, L. E., Small, A. M., & Gonzalez-Lima, F. (2007) · Journal of Histotechnology · doi:10.1179/014788807794775512 · Cited by 12
The Anterior Visual System and Circadian Function with Reference to Alzheimer's Disease
Valenti, D. A. (2004) · KARGER eBooks · doi:10.1159/000079995 · Cited by 11
Chemical Organization of the Human Cerebral Cortex
Hornung, J., & de Tribolet, N. (1995) · Advances in behavioral biology · doi:10.1007/978-1-4615-1853-2_4 · Cited by 13
Duong, T., & Gallagher, K. A. (1994) · Molecular and Chemical Neuropathology · doi:10.1007/bf03160099 · Cited by 11
“This coincides with previous observations that the number of NFT was always higher in layer V of AD brains ( Hof et al., 1990 ).”
BackgroundResultInfluentialSaleem, K. S., Avram, A. V., Yen, C. C., Magdoom, K. N., Schram, V., & Basser, P. J. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120311 · Cited by 10
“It is also a valuable stain for a vulnerable subset of pyramidal neurons in the visual, temporal, and frontal cortical areas visualized in postmortem brain of Alzheimer’s disease cases (Hof et al., 1990; Hof and Morrison, 1990; Thangavel et al., 2009).”
The Subcortical Atlas of the Marmoset (“SAM”) monkey based on high-resolution MRI and histology
Saleem, K. S., Avram, A. V., Glen, D., Schram, V., & Basser, P. J. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae120 · Cited by 13
Tau, atrophy, and domain‐specific cognitive impairment in typical Alzheimer's disease
Wuestefeld, A., Xie, L., McGrew, E., Binette, A. P., Spotorno, N., van Westen, D., Mattsson, N., Yushkevich, P. A., Das, S. R., Wolk, D. A., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70511 · Cited by 12
Individual variability in the size and organization of the human arcuate nucleus of the medulla
Baizer, J. S., Webster, C. J., & Witelson, S. F. (2021) · Brain Structure and Function · doi:10.1007/s00429-021-02396-4 · Cited by 9
Maj, M. A., Gehani, T. R., Immoos, C. E., Medrano, M. S., Fanter, R. K., Strand, C. R., Glanz, H., Piccolo, B. D., Abo-Ismail, M. K., Frano, M. R. L., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12091193 · Cited by 9
“In addition, neurons in the FC are among the first to deteriorate in AD patients [46].”
BackgroundNeurofilament-Immunoreactive Neurons Are Not Selectively Vulnerable in Alzheimer's Disease
Shepherd, C. E., Thiel, E., McCann, H., & Halliday, G. M. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0361 · Cited by 9
“Previous anatomical studies have demonstrated a dramatic loss of nonphosphorylated neurofilament (200 kDa) protein in AD, as detected by the Sternberger monoclonal antibody SMI32 (Duong & Gallagher, 1994; Hof et al., 1990; Morrison et al., 1987).”
BackgroundResultMVNet: Multi-Variate Multi-View Brain Network Comparison Over Uncertain Data
Shi, L., Hu, J., Tan, Z.-H., Tao, J., Ding, J., Jin, Y., Wu, Y., & Thompson, P. M. (2021) · IEEE Transactions on Visualization and Computer Graphics · doi:10.1109/tvcg.2021.3098123 · Cited by 11
“In early research of AD [74], certain types of pyramidal neurons were reported to be lost in the superior frontal (#64) and inferior temporal (#10 and #45) cortex.”
BackgroundCytoarchitectonic gradients of laminar degeneration in behavioural variant frontotemporal dementia
Ohm, D. T., Xie, S. X., Capp, N., Arezoumandan, S., Cousins, K. A. Q., Rascovsky, K., Wolk, D. A., Deerlin, V. M. V., Lee, E. B., McMillan, C. T., et al. (2024) · Brain · doi:10.1093/brain/awae263 · Cited by 11
Tian, Y., Li, D., Wang, D., Zhu, T., Xia, M., & Jiang, W. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220691 · Cited by 12
“SinceBA39andBA40,locatedinthe temporo-occipitalregion,arethoughttobeassoci-atedwithlanguageprocessing[86],thedepositionof neurofibrillarytanglesintheinferiortemporalcor-texindicatesmoreseverememoryimpairmentand dementiarisk[87].”
Morphological Changes in Human Cerebral Cortex during Normal Aging
Bussière, T., & Hof, P. R. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50009-3 · Cited by 9
Self-citationA Novel Form of Compensation in the Tg2576 Amyloid Mouse Model of Alzheimer’s Disease
Somogyi, A., Katonai, Z., Alpár, A., & Wolf, E. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00152 · Cited by 7
“Neurons in layers II/III of primary somatosensory cortex represent one of the most severely affected neuron populations in AD (Hof et al., 1990; Hampel et al., 1998; Bussiere et al., 2003; Hof and Morrison, 2004).”
BackgroundInfluentialCortical Feedforward and Cortical Feedback Neural Systems in Alzheimer’s Disease
Hoesen, G. W. V. (1997) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-60680-9_2 · Cited by 8
Normal Aging and Alzheimer's Disease
Hyman, B. T., & Gómez‐Isla, T. (1998) · Elsevier eBooks · doi:10.1016/b978-012734610-6/50006-3 · Cited by 9
Neurofilament heavy phosphorylated epitopes as biomarkers in ageing and neurodegenerative disease
Paoli, L. F. D., Kirkcaldie, M., King, A. E., & Collins, J. M. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16261 · Cited by 7
“…versus aged controls – ELISA (Hu et al., 2002) Longitudinal decrease (6 months) in CSF pNFH—ELISA (Höglund et al., 2012) Decrease in npNFH-ir neurons (Hof et al., 1990) Plaque-associated dystrophic neurites, np/p/hpNFH-ir (Cras et al., 1991 ; Dickson et al., 1999) FTD Pre-synaptic spheroidal…”
InfluentialZhao, Z., Cao, Z., Zhu, Q., Xu, H., Li, S., Zhu, L., Xu, G., Zhu, K., Zhang, J., & Wu, D. (2025) · Human Brain Mapping · doi:10.1002/hbm.70222 · Cited by 8
“Tau accumulation in AD also showed layer dependence, with layers II–III and V of the frontotemporal cortex (Bussière et al. 2003; Hof et al. 1990) and layer II of the entorhinal cortex (Gómez-Isla et al. 1996) being vulnerable to the laminar distribution of NFTs. Similarly, our study observed…”
Molecular signatures of regional vulnerability to tauopathy in excitatory cortical neurons
Broekaart, D. W. M., Sharma, A., Ramakrishnan, A., Chongtham, A., Günther, D. M., Subramaniyan, S., Wang, M., Patel, V., Zhang, B., Grinberg, L. T., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02879-2 · Cited by 11
Self-citationSpecies Differences in the Organization of the Ventral Cochlear Nucleus
Baizer, J. S., Wong, K. M., Salvi, R., Manohar, S., Sherwood, C. C., Hof, P. R., Baker, J. F., & Witelson, S. F. (2017) · The Anatomical Record · doi:10.1002/ar.23751 · Cited by 7
“It has been widely used to characterize cortical pyramidal cells in several species (Hof et al., 1990; Hof and Morrison, 1995; Van der Gucht et al., 2007).”
Self-citationOn the occurrence of neuronal sprouting in the frontal cortex of a patient with Down's syndrome
Ohara, S., Tsukada, M., & Ikeda, S.-I. (1999) · Acta Neuropathologica · doi:10.1007/s004010050959 · Cited by 7
“Hof et al. [9] demonstrated that large pyramidal neurons located within layers III and V are particularly vulnerable in AD [ 9 ].”
BackgroundRamírez‐Toraño, F., Abbas, K., Bruña, R., Pedro, S. M.-D., Gómez‐Ruiz, N., Barabash, A., Pereda, E., Marcos, A., López-Higes, R., Maestú, F., et al. (2021) · Cerebral Cortex Communications · doi:10.1093/texcom/tgab051 · Cited by 8
“Nevertheless, the early disruption of the WM integrity could be due to an initial effect of the tau-pathology associated with AD since pyramidal neurons in the temporal cortex prone to be particularly vulnerable to tau-pathology (Hof et al. 1990).”
BackgroundVaucher, E., Pierret, P., Julien, J., & Kuchel, G. A. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00010-0 · Cited by 6
Metadata
- Authors
- Hof, P. R., Morrison, J. H., & Cox, K.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- University of California San Diego (US)
- Venue
- Journal of Comparative Neurology
- Publisher
- Wiley
- Published
- 1990-11
- Volume
- 301
- Issue
- 1
- Pages
- 44-54
- ISSN
- 0021-9967 (ISSN-L)
- 1096-9861
- OpenAlex
- W2049691406
- Cited by
- 365
- References
- 76
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 13 · 2023: 9 · 2022: 8 · 2021: 18 · 2020: 4 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 10 · 2015: 8 · 2014: 8 · 2013: 4 · 2012: 2
- FWCI
- 11.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Comparative Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG 05138, P50AG005138, AG-06647)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, pyramidal neurons, neurofilament proteins, neuronal vulnerability, superior frontal cortex, inferior temporal cortex, neurofibrillary tangles, neuronal loss, corticocortical connections
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Antibodies, Monoclonal, Cerebral Cortex, Dendrites, Frontal Lobe, Humans, Immunohistochemistry, Intermediate Filament Proteins, Neurons, Occipital Lobe, Pyramidal Tracts, Temporal Lobe, Neurofilament Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.